## **Core Concept**
The treatment of advanced prostate cancer often involves hormonal therapy, also known as androgen deprivation therapy (ADT), aimed at reducing levels of male hormones (androgens) such as testosterone and dihydrotestosterone (DHT) that fuel the growth of prostate cancer cells.

## **Why the Correct Answer is Right**
Leuprolide, a gonadotropin-releasing hormone (GnRH) agonist, is useful in the treatment of advanced prostate cancer. It works by initially stimulating and then downregulating the pituitary gland's GnRH receptors, leading to a decrease in the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This decrease results in reduced production of testosterone by the testes, effectively starving the prostate cancer cells of the androgens they need to grow.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is blank and cannot be evaluated.
- **Option D:** This option is blank and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that GnRH agonists like leuprolide can cause an initial flare of symptoms (tumor flare reaction) due to the initial surge in testosterone levels before downregulation occurs. This is managed by starting anti-androgens like flutamide concurrently.

## **Correct Answer:** . Leuprolide